


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 16 Sep 2007
Teva Announces Appointment of Isaac Abravanel as Corporate Vice President, Human Resources
Teva Announces Appointment of Isaac Abravanel as Corporate Vice President, Human Resources
HSMN NewsFeed - 14 Sep 2007
Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
HSMN NewsFeed - 14 Sep 2007
Neurogen Corporation Announces Appointment of Stephen R. Davis as President
Neurogen Corporation Announces Appointment of Stephen R. Davis as President
HSMN NewsFeed - 14 Sep 2007
Canadian Regulatory Authority has Accepted for Review New Drug Submission for Ceftobiprole
Canadian Regulatory Authority has Accepted for Review New Drug Submission for Ceftobiprole
HSMN NewsFeed - 13 Sep 2007
VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
HSMN NewsFeed - 13 Sep 2007
Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
HSMN NewsFeed - 13 Sep 2007
FDA To Continue Its Review of Requests for Release of Clinical Hold on alvimopan (Entereg(R))
FDA To Continue Its Review of Requests for Release of Clinical Hold on alvimopan (Entereg(R))
HSMN NewsFeed - 13 Sep 2007
PTC Therapeutics Announces $20 Million Strategic Investment From Celgene Corporation
PTC Therapeutics Announces $20 Million Strategic Investment From Celgene Corporation
HSMN NewsFeed - 13 Sep 2007
Encysive Pharmaceuticals Announces Launch of THELIN (sitaxentan sodium) in Spain
Encysive Pharmaceuticals Announces Launch of THELIN (sitaxentan sodium) in Spain
HSMN NewsFeed - 12 Sep 2007
FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
HSMN NewsFeed - 12 Sep 2007
Flamel Technologies Announces Medusa(R) License Agreement with Wyeth Pharmaceuticals
Flamel Technologies Announces Medusa(R) License Agreement with Wyeth Pharmaceuticals
HSMN NewsFeed - 12 Sep 2007
Innocoll Enters Into Collaboration With TGR Biosciences for Development of a Novel Wound Healing Product
Innocoll Enters Into Collaboration With TGR Biosciences for Development of a Novel Wound Healing Product
HSMN NewsFeed - 12 Sep 2007
Micromet Appoints Mark Reisenauer as Senior Vice President and Chief Commercial Officer
Micromet Appoints Mark Reisenauer as Senior Vice President and Chief Commercial Officer
HSMN NewsFeed - 11 Sep 2007
Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
HSMN NewsFeed - 11 Sep 2007
Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee
Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee
HSMN NewsFeed - 11 Sep 2007
Stellar Pharmaceuticals Agrees to Settle Dispute with European Uracyst Licensee
Stellar Pharmaceuticals Agrees to Settle Dispute with European Uracyst Licensee
HSMN NewsFeed - 11 Sep 2007
Opexa Therapeutics Gives Update on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis
Opexa Therapeutics Gives Update on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis
HSMN NewsFeed - 11 Sep 2007
Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
HSMN NewsFeed - 11 Sep 2007
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
HSMN NewsFeed - 10 Sep 2007
Obagi Medical Products Reorganizes International Sales and Manufacturing/Distribution Business Units
Obagi Medical Products Reorganizes International Sales and Manufacturing/Distribution Business Units
HSMN NewsFeed - 10 Sep 2007
Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX(TM) U.S. Pivotal Phase III Study
Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX(TM) U.S. Pivotal Phase III Study
HSMN NewsFeed - 10 Sep 2007
Resolvyx Pharmaceuticals Hires James Nichols as EVP of Corporate Development
Resolvyx Pharmaceuticals Hires James Nichols as EVP of Corporate Development
HSMN NewsFeed - 10 Sep 2007
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
HSMN NewsFeed - 10 Sep 2007
BioVascular, Inc. Merges with Revitus and Acquires First-In-Class Platelet Count Reducer
BioVascular, Inc. Merges with Revitus and Acquires First-In-Class Platelet Count Reducer
HSMN NewsFeed - 10 Sep 2007
INNOVIVE Pharmaceuticals Acquires Exclusive Rights to Develop and Commercialize Tamibarotene in Europe
INNOVIVE Pharmaceuticals Acquires Exclusive Rights to Develop and Commercialize Tamibarotene in Europe
HSMN NewsFeed - 10 Sep 2007
Lev Pharmaceuticals Meets Primary Endpoint in Pivotal Phase III Prophylactic Trial for Hereditary Angioedema
Lev Pharmaceuticals Meets Primary Endpoint in Pivotal Phase III Prophylactic Trial for Hereditary Angioedema
HSMN NewsFeed - 10 Sep 2007
EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
HSMN NewsFeed - 10 Sep 2007
FDA Informs Endo and Vernalis That New Target Action Date on Frova(R) sNDA Is Sept. 30, 2007
FDA Informs Endo and Vernalis That New Target Action Date on Frova(R) sNDA Is Sept. 30, 2007
HSMN NewsFeed - 7 Sep 2007
RXi Pharmaceuticals Names Life Science Veteran Stephen J. DiPalma Chief Financial Officer
RXi Pharmaceuticals Names Life Science Veteran Stephen J. DiPalma Chief Financial Officer
HSMN NewsFeed - 6 Sep 2007
Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
HSMN NewsFeed - 6 Sep 2007
Cubist Pharmaceuticals' CUBICIN Approved for Additional Indications in the EU
Cubist Pharmaceuticals' CUBICIN Approved for Additional Indications in the EU
HSMN NewsFeed - 6 Sep 2007
Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
HSMN NewsFeed - 6 Sep 2007
Shire Appoints Anita Graham to the Newly Created Position of Chief Administrative Officer
Shire Appoints Anita Graham to the Newly Created Position of Chief Administrative Officer
HSMN NewsFeed - 5 Sep 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
HSMN NewsFeed - 5 Sep 2007
BDSI Secures U.S. Commercial Partnership for BEMA(TM) Fentanyl with Meda AB
BDSI Secures U.S. Commercial Partnership for BEMA(TM) Fentanyl with Meda AB
HSMN NewsFeed - 5 Sep 2007
Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
HSMN NewsFeed - 5 Sep 2007
GelStat Strengthens Its Management Team With the Addition of William ("Bill") Colucci as Its President
GelStat Strengthens Its Management Team With the Addition of William ("Bill") Colucci as Its President
HSMN NewsFeed - 5 Sep 2007
BioSante Pharmaceuticals Names Joy A. Thomas Vice President of Corporate Development
BioSante Pharmaceuticals Names Joy A. Thomas Vice President of Corporate Development
HSMN NewsFeed - 5 Sep 2007
Eisai Inc. Enters Copromotion Agreement with Salix Pharmaceuticals, Ltd. for Balsalazide Products
Eisai Inc. Enters Copromotion Agreement with Salix Pharmaceuticals, Ltd. for Balsalazide Products
HSMN NewsFeed - 5 Sep 2007
Bar Harbor BioTechnology Inc. Completes Series A Financing for Product Launch
Bar Harbor BioTechnology Inc. Completes Series A Financing for Product Launch
HSMN NewsFeed - 5 Sep 2007
Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
HSMN NewsFeed - 5 Sep 2007
Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
HSMN NewsFeed - 4 Sep 2007
Ensemble Discovery Names Michael D. Taylor, PhD as President and Chief Executive Officer
Ensemble Discovery Names Michael D. Taylor, PhD as President and Chief Executive Officer
HSMN NewsFeed - 4 Sep 2007
GTC Obtains FDA Fast Track Designation for ATryn(R) and Permission to Submit a Rolling BLA
GTC Obtains FDA Fast Track Designation for ATryn(R) and Permission to Submit a Rolling BLA
HSMN NewsFeed - 4 Sep 2007
NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
HSMN NewsFeed - 4 Sep 2007
Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
HSMN NewsFeed - 4 Sep 2007
Transdermal Patch Growth Relying on Improved Designs, Enhanced Manufacturing Methods
Transdermal Patch Growth Relying on Improved Designs, Enhanced Manufacturing Methods
HSMN NewsFeed - 3 Sep 2007
Nitec Pharma AG Announces Appointments of CEO & CFO in Preparation for Launch of Lodotra(R)
Nitec Pharma AG Announces Appointments of CEO & CFO in Preparation for Launch of Lodotra(R)
HSMN NewsFeed - 31 Aug 2007
Eligard(R) six-month formulation successfully completes European approval procedure
Eligard(R) six-month formulation successfully completes European approval procedure
HSMN NewsFeed - 31 Aug 2007
Ipsen: Somatuline(R) Depot Receives Marketing Approval in the United States for the Treatment of Acromegaly
Ipsen: Somatuline(R) Depot Receives Marketing Approval in the United States for the Treatment of Acromegaly
HSMN NewsFeed - 30 Aug 2007
Somatuline(R) Depot Receives FDA Marketing Approval for the Treatment of Acromegaly
Somatuline(R) Depot Receives FDA Marketing Approval for the Treatment of Acromegaly
HSMN NewsFeed - 30 Aug 2007
ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
HSMN NewsFeed - 30 Aug 2007
OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
HSMN NewsFeed - 30 Aug 2007
Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
HSMN NewsFeed - 30 Aug 2007
A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
HSMN NewsFeed - 30 Aug 2007
Hana Biosciences Appoints S. Michael Imperiale, Jr., M.D., as Vice President, Clinical Research Operations
Hana Biosciences Appoints S. Michael Imperiale, Jr., M.D., as Vice President, Clinical Research Operations
HSMN NewsFeed - 30 Aug 2007
Neurogen Corporation Announces Appointment of George D. Maynard to Vice President
Neurogen Corporation Announces Appointment of George D. Maynard to Vice President
HSMN NewsFeed - 30 Aug 2007
Pharming Presents Positive Results from European Phase III Trial of Rhucin(R)
Pharming Presents Positive Results from European Phase III Trial of Rhucin(R)
HSMN NewsFeed - 29 Aug 2007
FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
HSMN NewsFeed - 29 Aug 2007
Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
HSMN NewsFeed - 29 Aug 2007
Wyeth and Progenics Submit Marketing Application in Australia for Subcutaneous Methylnaltrexone
Wyeth and Progenics Submit Marketing Application in Australia for Subcutaneous Methylnaltrexone
HSMN NewsFeed - 28 Aug 2007
MGI PHARMA Signs Agreement for Rights to Novel Treatment for Thrombocytopenia
MGI PHARMA Signs Agreement for Rights to Novel Treatment for Thrombocytopenia
HSMN NewsFeed - 28 Aug 2007
Cubist Pharmaceuticals Creates COO Position, Adds Scientific Advisory Board
Cubist Pharmaceuticals Creates COO Position, Adds Scientific Advisory Board
HSMN NewsFeed - 28 Aug 2007
FDA Accepts for Review Complete Response to Approvable Letter for Entereg(R) (alvimopan) for POI
FDA Accepts for Review Complete Response to Approvable Letter for Entereg(R) (alvimopan) for POI
HSMN NewsFeed - 28 Aug 2007
Neuro-Hitech Announces the Appointment of Dr. Gary Shearman as President and Chief Executive Officer
Neuro-Hitech Announces the Appointment of Dr. Gary Shearman as President and Chief Executive Officer
HSMN NewsFeed - 28 Aug 2007
Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
HSMN NewsFeed - 28 Aug 2007
Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion
Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion
HSMN NewsFeed - 27 Aug 2007
First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
HSMN NewsFeed - 27 Aug 2007
Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
HSMN NewsFeed - 27 Aug 2007
BioLineRx In-Licenses Novel Drug for the Treatment of Acute Kidney Injury
BioLineRx In-Licenses Novel Drug for the Treatment of Acute Kidney Injury
HSMN NewsFeed - 27 Aug 2007
Dr. John Fara Retires as Chairman, President and CEO of Depomed; Mr. Carl Pelzel Appointed President and CEO
Dr. John Fara Retires as Chairman, President and CEO of Depomed; Mr. Carl Pelzel Appointed President and CEO
HSMN NewsFeed - 27 Aug 2007
Santarus Announces Co-Promotion Agreement for Fleet Phospho-soda EZ-Prep System
Santarus Announces Co-Promotion Agreement for Fleet Phospho-soda EZ-Prep System
HSMN NewsFeed - 27 Aug 2007
Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
HSMN NewsFeed - 24 Aug 2007
DNA Sequencing Equipment Market to Fragment and Grow as Competition, New Technologies Develop
DNA Sequencing Equipment Market to Fragment and Grow as Competition, New Technologies Develop
HSMN NewsFeed - 23 Aug 2007
Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
HSMN NewsFeed - 23 Aug 2007
Ventaira Pharmaceuticals Appoints Lex Adjei, Ph.D. as Vice President, Research and Development
Ventaira Pharmaceuticals Appoints Lex Adjei, Ph.D. as Vice President, Research and Development
HSMN NewsFeed - 23 Aug 2007
Cytochroma announces appointment of Gordon Ngan, CFA, MBA as Executive Director, Corporate Development
Cytochroma announces appointment of Gordon Ngan, CFA, MBA as Executive Director, Corporate Development
HSMN NewsFeed - 23 Aug 2007
Phase 3 Oncology Program for Aflibercept (VEGF Trap) Initiated by Regeneron and sanofi-aventis
Phase 3 Oncology Program for Aflibercept (VEGF Trap) Initiated by Regeneron and sanofi-aventis
HSMN NewsFeed - 23 Aug 2007
Antares Announces Initiation of Pivotal Trial of ANTUROL(TM) for the Treatment of Overactive Bladder
Antares Announces Initiation of Pivotal Trial of ANTUROL(TM) for the Treatment of Overactive Bladder
HSMN NewsFeed - 23 Aug 2007
Ipsen Transfers Ginkor Fort(R) Marketing Authorisations To GTF For France, Monaco and Andorra
Ipsen Transfers Ginkor Fort(R) Marketing Authorisations To GTF For France, Monaco and Andorra
HSMN NewsFeed - 22 Aug 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
HSMN NewsFeed - 22 Aug 2007
Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
HSMN NewsFeed - 22 Aug 2007
Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
HSMN NewsFeed - 21 Aug 2007
New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
HSMN NewsFeed - 21 Aug 2007
Neuromed Raises US$53.3 Million in Series E Financing to Accelerate Development of Pain Treatments
Neuromed Raises US$53.3 Million in Series E Financing to Accelerate Development of Pain Treatments
HSMN NewsFeed - 21 Aug 2007
Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
HSMN NewsFeed - 21 Aug 2007
Daiichi Sankyo and Forest Laboratories Sign Letter of Intent for Co-Promotion of AZOR(TM)
Daiichi Sankyo and Forest Laboratories Sign Letter of Intent for Co-Promotion of AZOR(TM)
HSMN NewsFeed - 21 Aug 2007
Inovio Biomedical Appoints Dr. Michael Fons as Vice President, Corporate Development
Inovio Biomedical Appoints Dr. Michael Fons as Vice President, Corporate Development
HSMN NewsFeed - 20 Aug 2007
PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
HSMN NewsFeed - 20 Aug 2007
Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
HSMN NewsFeed - 20 Aug 2007
Elixir Pharmaceuticals Initiates Final Phase III Clinical Study Prior to NDA
Elixir Pharmaceuticals Initiates Final Phase III Clinical Study Prior to NDA
HSMN NewsFeed - 20 Aug 2007
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
HSMN NewsFeed - 17 Aug 2007
Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and Quality Officer
Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and Quality Officer
HSMN NewsFeed - 17 Aug 2007
Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
HSMN NewsFeed - 17 Aug 2007
UCB Announces Submission of Lacosamide Marketing Application for Diabetic Neuropathic Pain
UCB Announces Submission of Lacosamide Marketing Application for Diabetic Neuropathic Pain
HSMN NewsFeed - 16 Aug 2007
AEterna Zentaris completes management team with the appointment of Chief Medical Officer
AEterna Zentaris completes management team with the appointment of Chief Medical Officer
HSMN NewsFeed - 16 Aug 2007
Pro-Pharmaceuticals Announces ''Compassionate Use'' IND for DAVANAT(R) to Treat Biliary Cancer Patient
Pro-Pharmaceuticals Announces ''Compassionate Use'' IND for DAVANAT(R) to Treat Biliary Cancer Patient
HSMN NewsFeed - 16 Aug 2007
Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
HSMN NewsFeed - 15 Aug 2007
Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
HSMN NewsFeed - 15 Aug 2007
Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
HSMN NewsFeed - 15 Aug 2007
Collegium Pharmaceutical Provides Update on Development of its Nasal Inhaled Steroid for Allergic Rhinitis
Collegium Pharmaceutical Provides Update on Development of its Nasal Inhaled Steroid for Allergic Rhinitis
HSMN NewsFeed - 15 Aug 2007
EKR Therapeutics Raises Over $13 Million in a Series C Financing Round From New and Existing Investors
EKR Therapeutics Raises Over $13 Million in a Series C Financing Round From New and Existing Investors
HSMN NewsFeed - 14 Aug 2007
GlaxoSmithKline's Application for Rotarix(R) is Accepted for Review by the FDA
GlaxoSmithKline's Application for Rotarix(R) is Accepted for Review by the FDA
HSMN NewsFeed - 14 Aug 2007
Phase II Clinical Trial Results for ADENTRI Published in Journal of the American College of Cardiology
Phase II Clinical Trial Results for ADENTRI Published in Journal of the American College of Cardiology
HSMN NewsFeed - 14 Aug 2007
BDSI Names David Blum, M.D. Vice President of Medical Affairs and Clinical Research
BDSI Names David Blum, M.D. Vice President of Medical Affairs and Clinical Research
HSMN NewsFeed - 14 Aug 2007
Icagen Announces Alliance with Pfizer in Ion Channel-Focused Therapeutics for Pain and Related Disorders
Icagen Announces Alliance with Pfizer in Ion Channel-Focused Therapeutics for Pain and Related Disorders
HSMN NewsFeed - 14 Aug 2007
Affymax(R) Names Robert F. Venteicher, Ph.D., Vice President, Technical Operations
Affymax(R) Names Robert F. Venteicher, Ph.D., Vice President, Technical Operations
HSMN NewsFeed - 14 Aug 2007
European Commission Grants Chelsea Therapeutics Two Orphan Medicinal Product Designations for Droxidopa
European Commission Grants Chelsea Therapeutics Two Orphan Medicinal Product Designations for Droxidopa
HSMN NewsFeed - 13 Aug 2007
Genta Announces Launch of Genasense(R) Named-Patient/Compassionate Use Program
Genta Announces Launch of Genasense(R) Named-Patient/Compassionate Use Program
HSMN NewsFeed - 13 Aug 2007
Joel Z. Melnick, MD joins Cytochroma as Vice President, Clinical & Regulatory Affairs
Joel Z. Melnick, MD joins Cytochroma as Vice President, Clinical & Regulatory Affairs
HSMN NewsFeed - 13 Aug 2007
Ophthotech Raises $36 Million; In-Licenses Two Compounds for Macular Degeneration
Ophthotech Raises $36 Million; In-Licenses Two Compounds for Macular Degeneration
HSMN NewsFeed - 13 Aug 2007
Inspire Pharmaceuticals Launches AzaSite(TM) in the United States for Ocular Infections
Inspire Pharmaceuticals Launches AzaSite(TM) in the United States for Ocular Infections
HSMN NewsFeed - 13 Aug 2007
TyRx Pharma, Inc., Announces the Hiring of Mark Citron as Vice President, Clinical and Regulatory Affairs
TyRx Pharma, Inc., Announces the Hiring of Mark Citron as Vice President, Clinical and Regulatory Affairs
HSMN NewsFeed - 10 Aug 2007
APP Receives Expedited Approval for the First and Only Generic Cefotetan Disodium for Injection
APP Receives Expedited Approval for the First and Only Generic Cefotetan Disodium for Injection
HSMN NewsFeed - 10 Aug 2007
Mylan Announces Final FDA Approval for Verapamil Hydrochloride Extended-Release Capsules (PM)
Mylan Announces Final FDA Approval for Verapamil Hydrochloride Extended-Release Capsules (PM)
HSMN NewsFeed - 10 Aug 2007
FDA Grants Additional Six Months Marketing Exclusivity for the High Blood Pressure Medicine Diovan(R)
FDA Grants Additional Six Months Marketing Exclusivity for the High Blood Pressure Medicine Diovan(R)
HSMN NewsFeed - 10 Aug 2007
MAP Pharmaceuticals Appoints Shashidhar Kori New Vice President of Clinical Development
MAP Pharmaceuticals Appoints Shashidhar Kori New Vice President of Clinical Development
HSMN NewsFeed - 10 Aug 2007
MAP Pharmaceuticals Promotes Stephen B. Shrewsbury to Position of Chief Medical Officer
MAP Pharmaceuticals Promotes Stephen B. Shrewsbury to Position of Chief Medical Officer
HSMN NewsFeed - 9 Aug 2007
Paladin And Glide Pharma Sign Exclusive Agreement for Novel Needle-Free Drug Delivery System
Paladin And Glide Pharma Sign Exclusive Agreement for Novel Needle-Free Drug Delivery System
HSMN NewsFeed - 9 Aug 2007
GeneraMedix Inc. Announces FDA Approval and Launch of Ampicillin and Sulbactam for Injection, USP
GeneraMedix Inc. Announces FDA Approval and Launch of Ampicillin and Sulbactam for Injection, USP
HSMN NewsFeed - 9 Aug 2007
Newly Created Hemosol BioPharma Inc. on the Hunt for Partnership, Licensing and Acquisition Targets
Newly Created Hemosol BioPharma Inc. on the Hunt for Partnership, Licensing and Acquisition Targets
HSMN NewsFeed - 9 Aug 2007
Tikvah Therapeutics Names Jack W. Callicutt Vice President and Chief Financial Officer
Tikvah Therapeutics Names Jack W. Callicutt Vice President and Chief Financial Officer
HSMN NewsFeed - 8 Aug 2007
Paladin Expands Distribution Agreement with Shire HGT to Include ELAPRASE(TM) (Idursulfase)
Paladin Expands Distribution Agreement with Shire HGT to Include ELAPRASE(TM) (Idursulfase)
HSMN NewsFeed - 8 Aug 2007
Medivation Names Robert Elfont, M.D., Ph.D., Vice President of Clinical Development
Medivation Names Robert Elfont, M.D., Ph.D., Vice President of Clinical Development
HSMN NewsFeed - 8 Aug 2007
BioCryst Appoints Elliott T. Berger, Ph.D., Senior Vice President of Regulatory Affairs
BioCryst Appoints Elliott T. Berger, Ph.D., Senior Vice President of Regulatory Affairs
HSMN NewsFeed - 8 Aug 2007
Rilonacept (IL-1 Trap) Granted FDA Priority Review for the Treatment of CAPS
Rilonacept (IL-1 Trap) Granted FDA Priority Review for the Treatment of CAPS
HSMN NewsFeed - 7 Aug 2007
Santarus Receives Notice of Paragraph IV Certification Against Patents for ZEGERID Capsules
Santarus Receives Notice of Paragraph IV Certification Against Patents for ZEGERID Capsules
HSMN NewsFeed - 7 Aug 2007
NeurAxon Appoints Robert Medve, M.D., as Chief Medical and Regulatory Officer
NeurAxon Appoints Robert Medve, M.D., as Chief Medical and Regulatory Officer
HSMN NewsFeed - 7 Aug 2007
Lux Granted Fast Track Designation by FDA for LX211 for the Treatment of Uveitis
Lux Granted Fast Track Designation by FDA for LX211 for the Treatment of Uveitis
HSMN NewsFeed - 7 Aug 2007
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
HSMN NewsFeed - 7 Aug 2007
Abraxis BioScience Receives FDA Approval for Oxytocin Injection 10 USP Units/mL in a 30 mL Vial
Abraxis BioScience Receives FDA Approval for Oxytocin Injection 10 USP Units/mL in a 30 mL Vial
HSMN NewsFeed - 6 Aug 2007
Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009
Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009
HSMN NewsFeed - 6 Aug 2007
Encysive Pharmaceuticals Files Request for Formal Dispute Resolution With U.S. FDA
Encysive Pharmaceuticals Files Request for Formal Dispute Resolution With U.S. FDA
HSMN NewsFeed - 6 Aug 2007
Abraxis BioScience Receives Final Approval for Fosphenytoin Sodium Injection, USP
Abraxis BioScience Receives Final Approval for Fosphenytoin Sodium Injection, USP
HSMN NewsFeed - 6 Aug 2007
Pfizer's SelzentryTM (Maraviroc) Tablets, Novel Treatment for HIV, Approved by FDA
Pfizer's SelzentryTM (Maraviroc) Tablets, Novel Treatment for HIV, Approved by FDA
HSMN NewsFeed - 6 Aug 2007
XOMA Appoints Steven B. Engle President, Chief Executive Officer and Director
XOMA Appoints Steven B. Engle President, Chief Executive Officer and Director
HSMN NewsFeed - 6 Aug 2007
Avalon Pharmaceuticals Appoints Bradley G. Lorimier Chairman of Board of Directors
Avalon Pharmaceuticals Appoints Bradley G. Lorimier Chairman of Board of Directors
HSMN NewsFeed - 2 Aug 2007
Teva Announces Approval of Generic Protonix(R) Delayed Release Tablets, 20 mg and 40 mg
Teva Announces Approval of Generic Protonix(R) Delayed Release Tablets, 20 mg and 40 mg
HSMN NewsFeed - 2 Aug 2007
PTC Therapeutics Appoints Theresa Natalicchio as Senior Vice President of Marketing and Sales
PTC Therapeutics Appoints Theresa Natalicchio as Senior Vice President of Marketing and Sales
HSMN NewsFeed - 2 Aug 2007
Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
HSMN NewsFeed - 2 Aug 2007
Barr Announces Departure of President and COO; CEO Downey to Assume Responsibilities
Barr Announces Departure of President and COO; CEO Downey to Assume Responsibilities
HSMN NewsFeed - 2 Aug 2007
Hollis-Eden Pharmaceuticals Names Scott M. Freeman, M.D., Chief Medical Officer
Hollis-Eden Pharmaceuticals Names Scott M. Freeman, M.D., Chief Medical Officer
HSMN NewsFeed - 1 Aug 2007
Dennis Fenton, Executive Vice President of Operations, Elects to Retire after 25 Years with Amgen
Dennis Fenton, Executive Vice President of Operations, Elects to Retire after 25 Years with Amgen
HSMN NewsFeed - 1 Aug 2007
Tobira Therapeutics Inc. Completes $31 Million Series A Financing and Names Management Team
Tobira Therapeutics Inc. Completes $31 Million Series A Financing and Names Management Team
HSMN NewsFeed - 1 Aug 2007
Deforolimus Approved as Nonproprietary Name for AP23573 - ARIAD's Novel mTOR Inhibitor
Deforolimus Approved as Nonproprietary Name for AP23573 - ARIAD's Novel mTOR Inhibitor
HSMN NewsFeed - 1 Aug 2007
Genta and Emisphere Technologies File IND with FDA for Oral Drug to Treat Bone Disease
Genta and Emisphere Technologies File IND with FDA for Oral Drug to Treat Bone Disease
HSMN NewsFeed - 1 Aug 2007
Orexo Establishes Sales Force in Nordic Markets, by Entering into a Joint Venture with ProStrakan
Orexo Establishes Sales Force in Nordic Markets, by Entering into a Joint Venture with ProStrakan
HSMN NewsFeed - 31 Jul 2007
Theravance Announces Appointment of Leonard M. Blum as Chief Commercial Officer
Theravance Announces Appointment of Leonard M. Blum as Chief Commercial Officer
HSMN NewsFeed - 31 Jul 2007
Gene Logic Recruits Pharmaceutical Executive as Senior Vice President of Clinical Development
Gene Logic Recruits Pharmaceutical Executive as Senior Vice President of Clinical Development
HSMN NewsFeed - 31 Jul 2007
Lev Pharmaceuticals Submits Biologics License Application for Cinryze(TM)
Lev Pharmaceuticals Submits Biologics License Application for Cinryze(TM)
HSMN NewsFeed - 31 Jul 2007
New Study Finds Tindamax(R) to be Effective, Well-Tolerated Treatment for Bacterial Vaginosis
New Study Finds Tindamax(R) to be Effective, Well-Tolerated Treatment for Bacterial Vaginosis
HSMN NewsFeed - 31 Jul 2007
Neuren to Obtain Late Stage Compound Through Hamilton Pharmaceuticals Acquisition
Neuren to Obtain Late Stage Compound Through Hamilton Pharmaceuticals Acquisition
HSMN NewsFeed - 31 Jul 2007
FDA Advisory Panel Votes 22 to 1 for Avandia(R) to Remain Available to Patients in the US
FDA Advisory Panel Votes 22 to 1 for Avandia(R) to Remain Available to Patients in the US
HSMN NewsFeed - 30 Jul 2007
Amira Pharmaceuticals Announces Appointment of First Chief Executive Officer
Amira Pharmaceuticals Announces Appointment of First Chief Executive Officer
HSMN NewsFeed - 30 Jul 2007
Urigen Pharmaceuticals, Inc., formerly Valentis, Inc. Announces Name Change and New Stock Symbol
Urigen Pharmaceuticals, Inc., formerly Valentis, Inc. Announces Name Change and New Stock Symbol
HSMN NewsFeed - 30 Jul 2007
Bridge Announces Executive Management Selections: Appointment of CEO, Selection of CSO and Promotion of CFO
Bridge Announces Executive Management Selections: Appointment of CEO, Selection of CSO and Promotion of CFO
HSMN NewsFeed - 30 Jul 2007
Elusys Appoints New Chairman of the Board and a Vice President of Development
Elusys Appoints New Chairman of the Board and a Vice President of Development
HSMN NewsFeed - 30 Jul 2007
KV Pharmaceutical Announces U.S. Food and Drug Administration Approval of EvaMist(TM)
KV Pharmaceutical Announces U.S. Food and Drug Administration Approval of EvaMist(TM)
HSMN NewsFeed - 30 Jul 2007
SoloSTAR(R), the First Prefilled Disposable Insulin Pen for Lantus(R), is Now Available in the United States
SoloSTAR(R), the First Prefilled Disposable Insulin Pen for Lantus(R), is Now Available in the United States
HSMN NewsFeed - 30 Jul 2007
Lybrel, First Low Dose Combination Oral Contraceptive with Unique 365-Day Dosing, Now Available in U.S.
Lybrel, First Low Dose Combination Oral Contraceptive with Unique 365-Day Dosing, Now Available in U.S.
HSMN NewsFeed - 27 Jul 2007
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
HSMN NewsFeed - 27 Jul 2007
Reliant Pharmaceuticals Names Fred Craves, Ph.D. as Chairman of the Board of Directors
Reliant Pharmaceuticals Names Fred Craves, Ph.D. as Chairman of the Board of Directors
HSMN NewsFeed - 27 Jul 2007
OSI Pharmaceuticals Announces Agreement to Divest Anti-Platelet Derived Growth Factor (PDGF) Program
OSI Pharmaceuticals Announces Agreement to Divest Anti-Platelet Derived Growth Factor (PDGF) Program
HSMN NewsFeed - 27 Jul 2007
Positive Aggrastat(R) Results Versus Integrilin(R) Featured in American Heart Journal
Positive Aggrastat(R) Results Versus Integrilin(R) Featured in American Heart Journal
HSMN NewsFeed - 27 Jul 2007
Akorn, Inc. Announces FDA Approval of Ketotifen Fumarate Ophthalmic Solution, 0.025%
Akorn, Inc. Announces FDA Approval of Ketotifen Fumarate Ophthalmic Solution, 0.025%
HSMN NewsFeed - 27 Jul 2007
Sepracor Submits LUNIVIA(R) (LUNESTA(R) in U.S.) Marketing Authorization Application (MAA) for Europe
Sepracor Submits LUNIVIA(R) (LUNESTA(R) in U.S.) Marketing Authorization Application (MAA) for Europe
HSMN NewsFeed - 27 Jul 2007
Marketing Authorization Application for Satraplatin Accepted for Review by the European Medicines Agency
Marketing Authorization Application for Satraplatin Accepted for Review by the European Medicines Agency
HSMN NewsFeed - 26 Jul 2007
Ranbaxy and GlaxoSmithKline Enter Into an Agreement to Settle Valacyclovir U.S. Patent Litigation
Ranbaxy and GlaxoSmithKline Enter Into an Agreement to Settle Valacyclovir U.S. Patent Litigation
HSMN NewsFeed - 26 Jul 2007
Peregrine Pharmaceuticals Adds Pharmaceutical Executive as Head of Business Development for Asia and Europe
Peregrine Pharmaceuticals Adds Pharmaceutical Executive as Head of Business Development for Asia and Europe
HSMN NewsFeed - 26 Jul 2007
Alfacell and US Pharmacia Announce ONCONASE(R) Distribution Agreement for Eastern Europe
Alfacell and US Pharmacia Announce ONCONASE(R) Distribution Agreement for Eastern Europe
HSMN NewsFeed - 26 Jul 2007
BioCryst Announces Realignment and Strengthening of the Company's Executive Management Team
BioCryst Announces Realignment and Strengthening of the Company's Executive Management Team
HSMN NewsFeed - 25 Jul 2007
FDA Accepts Innovative Drug Application - ImmunoMod Begins Diabetes Therapeutic Trials
FDA Accepts Innovative Drug Application - ImmunoMod Begins Diabetes Therapeutic Trials
HSMN NewsFeed - 25 Jul 2007
Merck & Co., Inc. to Acquire NovaCardia, Inc., to Boost Clinical Pipeline of Cardiovascular Drug Candidates
Merck & Co., Inc. to Acquire NovaCardia, Inc., to Boost Clinical Pipeline of Cardiovascular Drug Candidates
HSMN NewsFeed - 25 Jul 2007
A.T.S. Pharmaceuticals, A division of Auriga Laboratories Launches Xyralid(TM) LP Lotion
A.T.S. Pharmaceuticals, A division of Auriga Laboratories Launches Xyralid(TM) LP Lotion
HSMN NewsFeed - 25 Jul 2007
New Head-to-Head Study Comparing LEXIVA(R) and Atazanavir Show Similar Efficacy and Lipid Changes
New Head-to-Head Study Comparing LEXIVA(R) and Atazanavir Show Similar Efficacy and Lipid Changes
HSMN NewsFeed - 25 Jul 2007
Antares Reaches Agreement with FDA on Special Protocol Assessment for Pivotal Trial of Anturol(TM)
Antares Reaches Agreement with FDA on Special Protocol Assessment for Pivotal Trial of Anturol(TM)
HSMN NewsFeed - 25 Jul 2007
Fourth ACTEMRA(TM) (tocilizumab) Phase III Study Demonstrates Significant Clinical Benefit in RA Patients
Fourth ACTEMRA(TM) (tocilizumab) Phase III Study Demonstrates Significant Clinical Benefit in RA Patients
HSMN NewsFeed - 25 Jul 2007
Maraviroc Reduces HIV Viral Load in Treatment-Naive Patients, 48 Week Data Show
Maraviroc Reduces HIV Viral Load in Treatment-Naive Patients, 48 Week Data Show
HSMN NewsFeed - 24 Jul 2007
Advanced Magnetics, Inc. Announces Name Change to AMAG Pharmaceuticals, Inc.
Advanced Magnetics, Inc. Announces Name Change to AMAG Pharmaceuticals, Inc.
HSMN NewsFeed - 24 Jul 2007
Cerenis Therapeutics Announces the Addition of Three Pharmaceutical Industry Veterans to its Management Team
Cerenis Therapeutics Announces the Addition of Three Pharmaceutical Industry Veterans to its Management Team
HSMN NewsFeed - 24 Jul 2007
Icagen Announces Filing of IND for ICA-105665, a Novel Compound for the Treatment of Epilepsy
Icagen Announces Filing of IND for ICA-105665, a Novel Compound for the Treatment of Epilepsy
HSMN NewsFeed - 24 Jul 2007
Neurochem granted Fast Track designation from U.S. FDA for tramiprosate (ALZHEMED(TM))
Neurochem granted Fast Track designation from U.S. FDA for tramiprosate (ALZHEMED(TM))
HSMN NewsFeed - 23 Jul 2007
Merrimack Pharmaceuticals Names William Slichenmyer, M.D. Senior Vice President and Chief Medical Officer
Merrimack Pharmaceuticals Names William Slichenmyer, M.D. Senior Vice President and Chief Medical Officer
HSMN NewsFeed - 23 Jul 2007
TYSABRI(R) Celebrates One-Year Anniversary as a Treatment for Multiple Sclerosis
TYSABRI(R) Celebrates One-Year Anniversary as a Treatment for Multiple Sclerosis
